Soligenix Leads Rare Disease Fight as Aging Population Strains Healthcare
December 4, 2025 — Soligenix advances rare disease therapies as chronic illnesses strain U.S. healthcare. Learn about HyBryte for CTCL and how biotech companies address unmet medical needs in aging populations.